Table 3.
Hospitalization | No hospitalization | P | |
LVEF (%) | 48 ± 18 | 49 ± 17 | 0.7 |
IVS (mm) | 12 ± 3 | 11 ± 3 | 0.14 |
LA (mm) | 50 ± 9 | 48 ± 10 | 0.15 |
GF (MDRD) | 56 ± 19 | 64 ± 21 | 0.01 |
Hemoglobin (g/L) | 127 ± 22 | 132 ± 20 | 0.16 |
Na+ (mEq/mL) | 139 ± 3.7 | 140 ± 3.6 | 0.4 |
K+ (mEq/mL) | 4.2 ± 0.5 | 4.3 ± 0.6 | 0.3 |
Systolic BP (mmHg) | 124 ± 18 | 125 ± 20 | 0.9 |
Diastolic BP (mmHg) | 73 ± 11 | 72 ± 13 | 0.7 |
CA125 (KU/L) | 58 ± 85 | 34 ± 61 | 0.01 |
NT-proBNP (pg/dL) | 3431 ± 4792 | 2031 ± 3234 | 0.03 |
AF (%) | 61 | 39 | 0.01 |
NYHA class III (%) | 97 | 3 | 0.0001 |
LVEF: Left ventricular ejection fraction; IVS: Interventricular septum; LA: Left atrial; GF: Glomerular filtration; Na: Sodium; K: Potassium; BP: Blood pressure; CA125: Carbohydrate antigen 125; NT-proBNP: N-terminal pro-B-type natriuretic peptide; AF: Atrial fibrillation; NYHA: New York Heart Association.